These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 11358850

  • 21. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR, Bahnassy AA, Hafez M, El-Shehaby AM, Sherif GM, Khaled HM, Zakhary N.
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [Abstract] [Full Text] [Related]

  • 22. Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma.
    Nambu S, Inoue K, Saski H.
    Jpn J Cancer Res; 1987 Jul; 78(7):695-704. PubMed ID: 3040653
    [Abstract] [Full Text] [Related]

  • 23. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 24. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
    Tangkijvanich P, Hourpai N, Rattanatanyong P, Wisedopas N, Mahachai V, Mutirangura A.
    Clin Chim Acta; 2007 Apr 15; 379(1-2):127-33. PubMed ID: 17303099
    [Abstract] [Full Text] [Related]

  • 25. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
    Bollati V, Fabris S, Pegoraro V, Ronchetti D, Mosca L, Deliliers GL, Motta V, Bertazzi PA, Baccarelli A, Neri A.
    Carcinogenesis; 2009 Aug 15; 30(8):1330-5. PubMed ID: 19531770
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Feb 15; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
    Fautrel A, Andrieux L, Musso O, Boudjema K, Guillouzo A, Langouët S.
    J Hepatol; 2005 Aug 15; 43(2):288-93. PubMed ID: 15922480
    [Abstract] [Full Text] [Related]

  • 33. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma.
    Yao D, Jiang D, Huang Z, Lu J, Tao Q, Yu Z, Meng X.
    Cancer; 2000 Feb 15; 88(4):761-9. PubMed ID: 10679644
    [Abstract] [Full Text] [Related]

  • 34. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [Abstract] [Full Text] [Related]

  • 35. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F.
    Clin Cancer Res; 2006 Oct 01; 12(19):5673-9. PubMed ID: 17020969
    [Abstract] [Full Text] [Related]

  • 36. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K, Miyoshi E, Gu J, Gao CX, Nakahara S, Kitada T, Honke K, Suzuki K, Yoshihara H, Yoshikawa K, Kawano K, Tonetti M, Kasahara A, Hori M, Hayashi N, Taniguchi N.
    Cancer Res; 2003 Oct 01; 63(19):6282-9. PubMed ID: 14559815
    [Abstract] [Full Text] [Related]

  • 37. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J.
    Am J Clin Pathol; 2006 May 01; 125(5):740-6. PubMed ID: 16707376
    [Abstract] [Full Text] [Related]

  • 38. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J, Qin Y, Li B, Sun Z, Yang B.
    Clin Biochem; 2006 Apr 01; 39(4):344-8. PubMed ID: 16527261
    [Abstract] [Full Text] [Related]

  • 39. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.
    Shen L, Fang J, Qiu D, Zhang T, Yang J, Chen S, Xiao S.
    Hepatogastroenterology; 1998 Apr 01; 45(23):1753-9. PubMed ID: 9840141
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.